Cytomegalovirus Infection and Atherosclerosis: A Systematic Review


1 Cardiovascular Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

2 Baqiyatallah Research Center for Gastroenterology & Liver Disease, Baqiyatallah University of Medical Sciences, Tehran, Iran

3 Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran


Cytomegalovirus (CMV) infection is one of the most common infections that affects humans’ cardiovascular system. Although the literature includes controversial evidence for any correlation between CMV infection and arterial atherosclerosis, the majority of studies, especially those with larger patient population and stronger data stand for such a relationship. However, the number of prospective studies was very limited. So, we believe that future studies should be directed towards prospective studies investigating either the impact of CMV infection or antiviral treatment on atherosclerosis formation and advancement in different patient populations including patients undergoing CABG and/or patients with moderate atherosclerosis. 


1. Kälvegren H. The Role of Chlamydia pneumoniae-induced Platelet Activation in Cardiovascular Disease. LTAB Linköpings Tryckeri AB, Sweden, 2007; p.18.

2. Paterson JC, Cottral GE. Experimental coronary sclerosis: lymphomatosis as a cause of coronary sclerosis in chickens. Arch Pathol 1950;49:699-709.

3. Fabricant CG, Fabricant J, Litrenta M, Minick C. Virus-induced atherosclerosis. J Exp Med 1978;148:335-40.

4. Minick CR, Fabricant CG, Fabricant J, Litrent M. Atherosclerosis induced by infection with a herpesvirus. Am J Pathol 1979; 96:673.

5. Crumpacker CS. Invited commentary: human cytomegalovirus, inflammation, cardiovascular disease, and mortality. Am J Epidemiol. 2010;172(4):372-4.

6. Nichols WG, Boeckh M. Recent advances in the therapy and prevention of CMV infections. J Clin Virol. 2000;16(1):25-40. Review.

7. Cascio A, Iaria C, Fries W. Cytomegalovirus pneumonia: a possible cause of death in patients with Crohn's disease. Am J Gastroenterol. 2013;108(3):454.

8. Boivin G, Chou S, Quirk MR, Erice A, Jordan MC. Detection of ganciclovir resistance mutations quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease. J Infect Dis. 1996;173(3):523-8.

9. Gredmark S, Jonasson L, Van Gosliga D, Ernerudh J, Söderberg-Nauclér C. Active cytomegalovirus replication in patients with coronary disease. Scand Cardiovasc J. 2007;41(4):230-4.

10. Mundkur LA, Rao VS, Hebbagudi S, Shanker J, Shivanandan H, Nagaraj RK, Kakkar VV. Pathogen burden, cytomegalovirus infection and inflammatory markers in the risk of premature coronary artery disease in individuals of Indian origin. Exp Clin Cardiol. 2012 Summer;17(2):63-8.

11. Rajasekhar D, Subramanyam G, Latheef SA, Vanajakshamma V, Srilatha A, Chaudhury A. Infectious aetiology in acute coronary syndromes. Indian J Med Microbiol. 2002;20(2):83-7.

12. Al-Ghamdi A. Role of herpes simplex virus-1, cytomegalovirus and Epstein-Barr virus in atherosclerosis. Pak J Pharm Sci. 2012;25(1):89-97.

13. Al-Ghamdi A, Jiman-Fatani AA, El-Banna H. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease. Pak J Pharm Sci. 2011;24(2):95-101.

14. Safaie N, Ghotaslou R, Montazer Ghaem H. Seroprevalence of cytomegalovirus in patients with and without coronary artery diseases at Madani Heart Center, Iran. Acta Med Iran. 2010;48(6):403-6.

15. Shanker J, Maitra A, Rao VS, Mundkur L, Dhanalakshmi B, Hebbagodi S, Kakkar VV. Rationale, design & preliminary findings of the Indian Atherosclerosis Research Study. Indian Heart J. 2010 Jul-Aug;62(4):286-95.

16. Jha HC, Prasad J, Mittal A. High immunoglobulin A seropositivity for combined Chlamydia pneumoniae, Helicobacter pylori infection, and high-sensitivity C-reactive protein in coronary artery disease patients in India can serve as atherosclerotic marker. Heart Vessels. 2008 Nov;23(6):390-6.

17. Jha HC, Mittal A. Coronary artery disease patient's first degree relatives may be at higher risk for atherosclerosis. Int J Cardiol. 2009;135(3):408-9; author reply 410. doi: 10.1016/j.ijcard.2008.03.031.

18. Rothenbacher D, Brenner H, Mertens T, Hoffmann MM, Hoffmeister A, Koenig W. Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease. BMC Cardiovasc Disord. 2005:5(1):10.

19. Heltai K, Kis Z, Burian K, Endresz V, Veres A, Ludwig E, Gönczöl E, Valyi-Nagy I. Elevated antibody levels against Chlamydia pneumoniae, human HSP60 and mycobacterial HSP65 are independent risk factors in myocardial infarction and ischaemic heart disease. Atherosclerosis. 2004;173(2):339-46.

20. Timóteo A, Ferreira J, Paixão P, Aguiar C, Teles R, Cardoso E, Silva JA, Marques T, Seabra-Gomes R. Serologic markers for cytomegalovirus in acute coronary syndromes. Rev Port Cardiol. 2003;22(5):619-31.

21. Grahame-Clarke C, Chan NN, Andrew D, Ridgway GL, Betteridge DJ, Emery V, Colhoun HM, Vallance P. Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation. 2003 Aug 12;108(6):678-83.

22. Altannavch Ts, Roubalová K, Broz J, Hrubá D, Andĕl M. Serological markers of Chlamydia pneumoniae, cytomegalovirus and Helicobacter pylori infection in diabetic and non-diabetic patients with unstable angina pectoris. Cent Eur J Public Health. 2003;11(2):102-6.

23. Khairy P, Rinfret S, Tardif JC, Marchand R, Shapiro S, Brophy J, Dupuis J. Absence of association between infectious agents and endothelial function in healthy young men. Circulation. 2003;107(15):1966-71. Epub 2003 Apr 7.

24. Witherell HL, Smith KL, Friedman GD, Ley C, Thom DH, Orentreich N, Vogelman JH, Parsonnet J. C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction. Ann Epidemiol. 2003;13(3):170-7.

25. Gattone M, Iacoviello L, Colombo M, Castelnuovo AD, Soffiantino F, Gramoni A, Picco D, Benedetta M, Giannuzzi P. Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age. Am Heart J. 2001;142(4):633-40.

26. Borgia MC, Mandolini C, Barresi C, Battisti G, Carletti F, Capobianchi MR. Further evidence against the implication of active cytomegalovirus infection in vascular atherosclerotic diseases. Atherosclerosis. 2001;157(2):457-62.

27. Weber C, von Stülpnagel C, Weber KS, Hengel H, Weber PC. Association of myocardial infarction with mononuclear cell expression of the cytomegalovirus chemokine receptor US28 in patients with NIDDM. Exp Clin Cardiol. 2001;6(2):105-8.

28. Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM, Epstein SE. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol. 2000 Jan 15;85(2):140-6.

29. George J, Ahmed A, Patnaik M, Adler Y, Levy Y, Harats D, Gilburd B, Terrybery J, Shen GQ, Sagie A, Herz I, Snow P, Brandt J, Peter J, Shoenfeld Y. The prediction of coronary atherosclerosis employing artificial neural networks. Clin Cardiol. 2000;23(6):453-6.

30. Zhu J, Quyyumi AA, Norman JE, Csako G, Epstein SE. Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. J Am Coll Cardiol. 1999 .15;34(6):1738-43.

31. Blum A, Giladi M, Weinberg M, Kaplan G, Pasternack H, Laniado S, Miller H. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol. 1998:1;81(7):866-8. Reff197

32. Adler SP, Hur JK, Wang JB, Vetrovec GW. Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J Infect Dis. 1998 Jan;177(1):209-12.

33. Ji YN, An L, Zhan P, Chen XH. Cytomegalovirus infection and coronary heart disease risk: a meta-analysis. Mol Biol Rep. 2012;39(6):6537-46. doi: 10.1007/s11033-012-1482-6.

34. Gabrylewicz B, Mazurek U, Ochała A, Sliupkas-Dyrda E, Garbocz P, Pyrlik A, Mróz I, Wilczok T, Tendera M. Cytomegalovirus infection in acute myocardial infarction. Is there a causative relationship? Kardiol Pol. 2003;59(10):283-92.

35. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, Hafner G, Pfeifer U, Meyer J. Are morphological or functional changes in the carotid artery wall associated with Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, or herpes simplex virus infection? Stroke. 2000;31(9):2127-33.

36. Nieto FJ, Sorlie P, Comstock GW, Wu K, Adam E, Melnick JL, Szklo M. Cytomegalovirus infection, lipoprotein(a), and hypercoagulability: an atherogenic link? Arterioscler Thromb Vasc Biol. 1997;17(9):1780-5.

37. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation. 1997 7;96(7):2144-8.

38. Merlini E, Luzi K, Suardi E, Barassi A, Cerrone M, Martínez JS, Bai F, D'Eril GV, Monforte AD, Marchetti G. T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis.PLoS One. 2012;7(9):e46073.

39. Müller BT, Huber R, Henrich B, Adams O, Berns G, Siebler M, Jander S, Müller W, Loncar R, Godehardt E, Sandmann W. Chlamydia pneumoniae, herpes simplex virus and cytomegalovirus in symptomatic and asymptomatic high-grade internal carotid artery stenosis. Does infection influence plaque stability? Vasa. 2005;34(3):163-9.

40. McDonald SP, Maguire GP, Duarte N, Wang XL, Hoy WE. Carotid intima-media thickness, cardiovascular risk factors and albuminuria in a remote Australian Aboriginal community. Atherosclerosis. 2004;177(2):423-31.

41. Nieto FJ, Adam E, Sorlie P, Farzadegan H, Melnick JL, Comstock GW, Szklo M. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation. 1996.1;94(5):922-7.

42. Sorlie PD, Adam E, Melnick SL, Folsom A, Skelton T, Chambless LE, Barnes R, Melnick JL. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC Study. J Med Virol. 1994;42(1):33-7.

43. Adam E, Melnick JL, Probtsfield JL, Petrie BL, Burek J, Bailey KR, McCollum CH, DeBakey ME. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet. 1987 8;2(8554):291-3.

44. Grub C, Brunborg C, Hasseltvedt V, Aukrust P, Førre O, Almdahl SM, Hollan I. Antibodies to common infectious agents in coronary artery disease patients with and without rheumatic conditions. Rheumatology (Oxford). 2012;51(4):679-85.

45. Nyberg A, Skagius E, Nilsson I, Ljungh A, Henriksson AE. Abdominal aortic aneurysm and cytomegalovirus infection. J Med Virol. 2008;80(4):667-9.

46. Rabczyński M, Adamiec R. Role of chronic infection and heat shock proteins in peripheral arterial disease. Przegl Lek. 2007;64(6):419-22.

47. Haarala A, Kähönen M, Lehtimäki T, Aittoniemi J, Jylhävä J, Hutri-Kähönen N, Taittonen L, Laitinen T, Juonala M, Viikari J, Raitakari OT, Hurme M. Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow-mediated dilation in young men: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol. 2012;167(2):309-16.

48. Bloemenkamp DG, Mali WP, Tanis BC, Rosendaal FR, van den Bosch MA, Kemmeren JM, Algra A, Ossewaarde JM, Visseren FL, van Loon AM, van der Graaf Y. Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women. Atherosclerosis. 2002 Jul;163(1):149-56.

49. van der Ven AJ, Hommels MJ, Kroon AA, Kessels A, Flobbe K, van Engelshoven J, Bruggeman CA, de Leeuw PW. Chlamydia pneumoniae seropositivity and systemic and renovascular atherosclerotic disease. Arch Intern Med. 2002 Apr 8;162(7):786-90.

50. Izadi M, Fazel M, Saadat SH, Nasseri MH, Ghasemi M, Dabiri H, Aryan RS, Esfahani AA, Ahmadi A, Kazemi-Saleh D, Kalantar-Motamed MH, Taheri S. Cytomegalovirus localization in atherosclerotic plaques is associated with acute coronary syndromes: report of 105 patients. Methodist Debakey Cardiovasc J. 2012;8(2):42-6.

51. Jha HC, Srivastava P, Divya A, Prasad J, Mittal A. Prevalence of Chlamydophila pneumoniae is higher in aorta and coronary artery than in carotid artery of coronary artery disease patients. APMIS. 2009 Dec;117(12):905-11.

52. Voorend M, van der Ven AJ, Kubat B, Lodder J, Bruggeman CA. Limited role for C. pneumoniae, CMV and HSV-1 in cerebral large and small vessel atherosclerosis. Open Neurol J. 2008;2:39-44.

53. Hagiwara N, Toyoda K, Inoue T, Shimada H, Ibayashi S, Iida M, Okada Y. Lack of association between infectious burden and carotid atherosclerosis in Japanese patients. J Stroke Cerebrovasc Dis. 2007;16(4):145-52.

54. Kilic A, Onguru O, Tugcu H, Kilic S, Guney C, Bilge Y. Detection of cytomegalovirus and Helicobacter pylori DNA in arterial walls with grade III atherosclerosis by PCR. Pol J Microbiol. 2006;55(4):333-7.

55. Pucar A, Milasin J, Lekovic V, Vukadinovic M, Ristic M, Putnik S, Kenney EB. Correlation between atherosclerosis and periodontal putative pathogenic bacterial infections in coronary and internal mammary arteries. J Periodontol. 2007;78(4):677-82.

56. Halvorsen DS, Karlsen J, Notø AT, Mathiesen EB, Njølstad I, Gutteberg TJ, Vorland LH, Hansen JB. No detectable Chlamydia pneumoniae and cytomegalovirus DNA in leukocytes in subjects with echolucent and echogenic carotid artery plaques. Int J Cardiol. 2007 May 2;117(3):388-94.

57. Liu R, Moroi M, Yamamoto M, Kubota T, Ono T, Funatsu A, Komatsu H, Tsuji T, Hara H, Hara H, Nakamura M, Hirai H, Yamaguchi T. Presence and severity of Chlamydia pneumoniae and Cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes. Int Heart J. 2006 Jul;47(4):511-9.

58. Westphal M, Lautenschlager I, Backhaus C, Loginov R, Kundt G, Oberender H, Stamm C, Steinhoff G. Cytomegalovirus and proliferative signals in the vascular wall of CABG patients. Thorac Cardiovasc Surg. 2006 Jun;54(4):219-26.

59. Latsios G, Saetta A, Michalopoulos NV, Agapitos E, Patsouris E. Detection of cytomegalovirus, Helicobacter pylori and Chlamydia pneumoniae DNA in carotid atherosclerotic plaques by the polymerase chain reaction. Acta Cardiol. 2004 Dec;59(6):652-7.

60. Ibrahim AI, Obeid MT, Jouma MJ, Moasis GA, Al-Richane WL, Kindermann I, Boehm M, Roemer K, Mueller-Lantzsch N, Gärtner BC. Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts. J Clin Virol. 2005 Jan;32(1):29-32.

61. Shi Y, Tokunaga O. Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol Int. 2002 Jan;52(1):31-9.

62. Hu W, Liu J, Niu S, Liu M, Shi H, Wei L. Prevalence of CMV in arterial walls and leukocytes in patients with atherosclerosis. Chin Med J (Engl). 2001 Nov;114(11):1208-10.

63. Rassu M, Cazzavillan S, Scagnelli M, Peron A, Bevilacqua PA, Facco M, Bertoloni G, Lauro FM, Zambello R, Bonoldi E. Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions. Atherosclerosis. 2001 Sep;158(1):73-9.

64. Saetta A, Fanourakis G, Agapitos E, Davaris PS. Atherosclerosis of the carotid artery: absence of evidence for CMV involvement in atheroma formation. Cardiovasc Pathol. 2000 May-Jun;9(3):181-3.

65. Horváth R, Cerný J, Benedík J Jr, Hökl J, Jelínková I, Benedík J. The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol. 2000 Feb;16(1):17-24.

66. Bartels C, Maass M, Bein G, Malisius R, Brill N, Bechtel JF, Sayk F, Feller AC, Sievers HH. Detection of Chlamydia pneumoniae but not cytomegalovirus in occluded saphenous vein coronary artery bypass grafts. Circulation. 1999 23;99(7):879-82.

67. Melnick JL, Hu C, Burek J, Adam E, DeBakey ME. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol. 1994;42(2):170-4. Reff216

68. Hendrix MG, Salimans MM, van Boven CP, Bruggeman CA. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol. 1990;136(1):23-8.

69. Gredmark-Russ S, Dzabic M, Rahbar A, Wanhainen A, Björck M, Larsson E, Michel JB, Söderberg-Nauclér C. Active cytomegalovirus infection in aortic smooth muscle cells from patients with abdominal aortic aneurysm. J Mol Med (Berl). 2009;87(4):347-56. doi: 10.1007/s00109-008-0413-4.

70. Reszka E, Jegier B, Wasowicz W, Lelonek M, Banach M, Jaszewski R. Detection of infectious agents by polymerase chain reaction in human aortic wall. Cardiovasc Pathol. 2008;17(5):297-302. doi: 10.1016/j.carpath.2007.11.002.

71. Radke PW, Merkelbach-Bruse S, Messmer BJ, vom Dahl J, Dörge H, Naami A, Vogel G, Handt S, Hanrath P. Infectious agents in coronary lesions obtained by endatherectomy: pattern of distribution, coinfection, and clinical findings. Coron Artery Dis. 2001;12(1):1-6.